Dr Andrew Steele
The Pioneer
The frontier and an appetite for the unknown, goes first.
Dr Andrew Steele emerges in this interview as a quintessential Pioneer, navigating the frontier where physics meets biology and where laboratory science meets economic and policy transformation. Steele traces his unconventional trajectory from Oxford physicist to computational biologist, driven not by convention but by the conviction that aging is biology's most consequential unsolved problem. His pioneering orientation is evident in how he reframes aging from an inevitability into an engineering challenge, marshaling evidence across species from naked mole rats to Galapagos tortoises to argue that senescence is not universal. Steele pushes past incremental medical thinking, insisting that targeting the hallmarks of aging represents a categorical shift in how medicine should be practiced. He actively identifies regulatory, funding, and investment frontiers that remain largely unexplored, positioning himself as someone charting territory others have not yet recognized as navigable.
“I thought this seems like a really big deal. This could potentially hit the root cause of many of the biggest killers in the modern world.”
“We have got an astonishing number of shots on goal in the sense that we've got dozens of ways to slow down aging in the lab and we just need to try some of these things in humans.”
“If you're a pension fund, maybe you should be thinking, is there a 1% chance that all my clients are suddenly going to live to 120?”
Money Maze Podcast: “Can We Live Longer? What it Might Mean for Medicine, Money, & Markets - With Dr Andrew Steele”
LISTEN AT THE SOURCE ↗THE RECORD IS CHECKABLE